Literature DB >> 32902816

A classic variant of Fabry disease in a family with the M296I late-onset variant.

Shuma Hirashio1, Reiko Kagawa2, Go Tajima3, Takao Masaki4.   

Abstract

Fabry disease is an X-linked recessive disease of glycosphingolipid metabolism caused by deficiency or reduced activity of α-galactosidase A. Fabry disease phenotypes are known to consist of a classic variant and a late-onset variant. In patients with Fabry disease, the phenotype is generally considered to be defined (at least partially) by the genotype. However, patients with the classic variant have been encountered in families with mutations that are expected to produce the late-onset variant. Here, we describe a 4-year-old boy with a classic variant of Fabry disease in a family with the M296I late-onset variant. The patient's grandfather, mother, and aunt experienced late-onset disease, characteristic of the M296I variant. Conversely, the patient experienced typical disease symptoms in childhood. He had symptoms of hypohidrosis and associated heat accumulation. He cried at night due to the occurrence of severe acroparaesthesia. This symptom became more pronounced in warmer climates. Although the patient's family had a late-onset variant mutation of Fabry disease, we determined that the patient's symptoms were similar to those of classic Fabry disease. Therefore, the patient began enzyme replacement therapy, which alleviated his symptoms. Notably, enzyme replacement therapy led to rapid improvement of the patient's subjective symptoms. Thus, we presumed that the patient's symptoms supported a diagnosis of classic Fabry disease. These findings suggest that childhood symptoms may occur in patients with Fabry disease, even in families with late-onset variant mutations. The genotype-phenotype correlation in Fabry disease remains controversial.

Entities:  

Keywords:  Classic variant; Fabry disease; Genotype; Late-onset variant; M296I mutation; Phenotype

Year:  2020        PMID: 32902816      PMCID: PMC7829310          DOI: 10.1007/s13730-020-00527-0

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  16 in total

1.  THE LYON HYPOTHESIS.

Authors:  J R ANDERSON
Journal:  Br Med J       Date:  1963-11-16

2.  Fabry disease and enzyme replacement therapy in classic patients with same mutation: different formulations--different outcome?

Authors:  J Politei; A B Schenone; G Cabrera; R Heguilen; M Szlago
Journal:  Clin Genet       Date:  2015-04-20       Impact factor: 4.438

Review 3.  The role of epigenetics in lysosomal storage disorders: Uncharted territory.

Authors:  Shahzeb Hassan; Ellen Sidransky; Nahid Tayebi
Journal:  Mol Genet Metab       Date:  2017-08-01       Impact factor: 4.797

4.  Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Authors:  Raphael Schiffmann; Derralynn A Hughes; Gabor E Linthorst; Alberto Ortiz; Einar Svarstad; David G Warnock; Michael L West; Christoph Wanner
Journal:  Kidney Int       Date:  2016-12-18       Impact factor: 10.612

5.  An atypical variant of Fabry's disease in men with left ventricular hypertrophy.

Authors:  S Nakao; T Takenaka; M Maeda; C Kodama; A Tanaka; M Tahara; A Yoshida; M Kuriyama; H Hayashibe; H Sakuraba
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

6.  The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.

Authors:  Markus Ries; Uma Ramaswami; Rossella Parini; Bengt Lindblad; Catharina Whybra; Ingrid Willers; Andreas Gal; Michael Beck
Journal:  Eur J Pediatr       Date:  2003-09-20       Impact factor: 3.183

7.  Intrafamilial phenotypic variability in four families with Anderson-Fabry disease.

Authors:  M Rigoldi; D Concolino; A Morrone; F Pieruzzi; R Ravaglia; F Furlan; F Santus; P Strisciuglio; G Torti; R Parini
Journal:  Clin Genet       Date:  2013-09-20       Impact factor: 4.438

8.  Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients.

Authors:  Tomoya Nishino; Yoko Obata; Akira Furusu; Misaki Hirose; Ken Shinzato; Kiyoko Hattori; Kimitoshi Nakamura; Tadashi Matsumoto; Fumio Endo; Shigeru Kohno
Journal:  Ren Fail       Date:  2012       Impact factor: 2.606

9.  High variability of Fabry disease manifestations in an extended Italian family.

Authors:  Giuseppe Cammarata; Pasquale Fatuzzo; Margherita Stefania Rodolico; Paolo Colomba; Luigi Sicurella; Francesco Iemolo; Carmela Zizzo; Riccardo Alessandro; Caterina Bartolotta; Giovanni Duro; Ines Monte
Journal:  Biomed Res Int       Date:  2015-04-22       Impact factor: 3.411

10.  Different renal phenotypes in related adult males with Fabry disease with the same classic genotype.

Authors:  Renzo Mignani; Mariarita Moschella; Giovanna Cenacchi; Ilaria Donati; Marta Flachi; Daniela Grimaldi; Davide Cerretani; Paola De Giovanni; Marcello Montevecchi; Angelo Rigotti; Alessandro Ravasio
Journal:  Mol Genet Genomic Med       Date:  2017-05-08       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.